TD-HP065016

Devextinetug(TD-HP065016) is a research-grade recombinant antibody targeting(+)-methamphetamine. Produced in mammalian cells with native-like glycosylation.HighlightsResearch Grade— For PK/PD studies, assay development, and ADA research.Native Glycosylation— Mammalian expression ensures native-like patterns.

General

ELISA, Bioactivity: FACS, Functional assay, Research in vivo

Human

IgG2-kappa

Monoclonal

(+)-methamphetamine

Please contact the lab for this information.

>95% purity as determined by SDS-PAGE.

Protein A/G purified from cell culture supernatant.

537-46-2

Liquid

0.01M PBS, pH 7.4.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.

CAS: 2609642-90-0

Devextinetug (IXT-M200) is a chimeric anti-methamphetamine, mouse-derived IgG2κ antibody.• Methamphetamine Use and Cardiovascular Disease., PMID:31433698• Methamphetamine deaths: Changing trends and diagnostic issues., PMID:33423599• Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A review., PMID:34166684• Methamphetamine-associated catatonia: Case series and systematic review of the literature from 1943-2020., PMID:37459499• Is Methamphetamine-Linked Cardiomyopathy an Emerging Epidemic for New Generation?, PMID:34780869• Zinc reduces the detection of cocaine, methamphetamine, and THC by ELISA urine testing., PMID:21740689• Household Contamination with Methamphetamine: Knowledge and Uncertainties., PMID:31771211• A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy., PMID:35157254• Methamphetamine-induced toxicity: The role of autophagy?, PMID:27746146• Mandatory treatment for methamphetamine use in Australia., PMID:33836785

SDS-PAGE for Research Grade Devextinetug.

For research use only. Not suitable for clinical or therapeutic use.